These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 27203738)
1. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection. Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738 [TBL] [Abstract][Full Text] [Related]
2. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy. Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086 [TBL] [Abstract][Full Text] [Related]
3. Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential. Gleeson FC; Kipp BR; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Graham RP; Lazaridis KN; Henry MR; Levy MJ Gastrointest Endosc; 2015 Sep; 82(3):550-6.e1. PubMed ID: 25887718 [TBL] [Abstract][Full Text] [Related]
4. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma. Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669 [TBL] [Abstract][Full Text] [Related]
5. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016 [TBL] [Abstract][Full Text] [Related]
6. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292 [TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA. Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909 [TBL] [Abstract][Full Text] [Related]
8. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma. Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731 [TBL] [Abstract][Full Text] [Related]
12. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms. Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer. Sibinga Mulder BG; Mieog JSD; Farina Sarasqueta A; Handgraaf HJ; Vasen HFA; Swijnenburg RJ; Luelmo SAC; Feshtali S; Inderson A; Vahrmeijer AL; Bonsing BA; Wezel TV; Morreau H J Clin Pathol; 2018 Mar; 71(3):246-252. PubMed ID: 28775172 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis. Bunduc S; Varzaru B; Iacob RA; Sorop A; Manea I; Spiridon A; Chelaru R; Croitoru AE; Becheanu G; Dumbrava M; Dima S; Popescu I; Gheorghe C World J Gastroenterol; 2023 May; 29(18):2864-2874. PubMed ID: 37274073 [TBL] [Abstract][Full Text] [Related]
15. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer. Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941 [TBL] [Abstract][Full Text] [Related]
17. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation. Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613 [TBL] [Abstract][Full Text] [Related]
18. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass]. Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M; Zavoral M Cas Lek Cesk; 2016; 155(1):48-51. PubMed ID: 26898792 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Dreyer SB; Jamieson NB; Evers L; Duthie F; Cooke S; Marshall J; Beraldi D; Knight S; Upstill-Goddard R; Dickson EJ; Carter CR; McKay CJ; Biankin AV; Chang DK Chin Clin Oncol; 2019 Apr; 8(2):16. PubMed ID: 31070037 [TBL] [Abstract][Full Text] [Related]
20. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples. Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]